Pharmacy benefit spending poised to increase for antithrombotic drug therapy -- prasugrel versus clopidogrel.

Full Abstract

No abstract is currently available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Curtiss, Frederic R (FR); Fairman, Kathleen A (KA);

Journal and publication information

Publication Type: Comment; Comparative Study; Editorial

Journal: Journal of managed care pharmacy : JMCP (J Manag Care Pharm), published in United States. (Language: eng)

Reference: 2009-Jun; vol 15 (issue 5) : pp 414-6

Dates: Created 2009/06/05; Completed 2009/07/09;

PMID: 19496638, status: MEDLINE (last retrieved date: 7/24/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: J Manag Care Pharm. 2009 Jun;15(5):383-95. (PMID: 19496635)

CommentOn: J Manag Care Pharm. 2009 May;15(4):335-43. (PMID: 19422273)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Commerce - trends
Drug Costs
Humans
Insurance, Pharmaceutical Services - economics; trends
Piperazines - economics; therapeutic use

Piperazines - economics; therapeutic use
Platelet Aggregation Inhibitors - economics; therapeutic use
Thiophenes - economics; therapeutic use
Thrombosis - economics; prevention & control
Ticlopidine - analogs & derivatives; economics; therapeutic use

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Piperazines (0) ; Platelet Aggregation Inhibitors (0) ; Thiophenes (0) ; prasugrel (0) ; Ticlopidine (55142-85-3) ; clopidogrel (90055-48-4)

These are the most related articles currently in our database:

See 100+ related articles.